Capital’s November 2014 and February 2015 decisions from recent P&T Committee meetings resulted in updates made to the open/closed and selectively closed formulary. Effective July 1, 2015 additional updates have been made to the Formulary & Utilization Management.
Updates included:
- Newly Marketed Drugs
- Products Changing Tier Status
- Pharmacy Utilization Management Programs
July 1, 2015 changes of note:
- Nasal steroids will require prior authorization
- Victrelis will be moving from brand preferred to brand non-preferred
July 1, 2015 CBC Drug Formulary & Utilization Management Updates